Steroid-Induced Hyperglycemia Successfully Treated With Once-Weekly Dulaglutide in an Old Patient With Type 2 Diabetes

Hidetaka Hamasaki, Shingo Morimitsu


Glucocorticoids induce hyperglycemia in case of pancreatic alpha- and beta-cell dysfunction. Glucagon-like peptide-1 receptor agonists (GLP-1RA) may prevent steroid-induced hyperglycemia by improving hyperglucagonemia and insulin secretion. An 85-year-old man was treated with oral prednisolone for chronic hypersensitivity pneumonitis, and his glycemic control deteriorated after the initiation of steroid therapy. After the administration of dulaglutide injection, his glycemic control was improved and we could discontinue insulin therapy. Both fasting and postprandial plasma glucagon levels were significantly suppressed by a GLP-1RA, dulaglutide. GLP-1RAs therapy may be a useful strategy for the treatment of steroid-induced hyperglycemia.

J Endocrinol Metab. 2018;8(1):10-12


Glucocorticoids; Glucagon-like peptide-1 receptor agonists; Glucagon; Insulin; Type 2 diabetes

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website:   editorial contact:
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.